Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Merkelbach-Bruse

Showing results (51-60 of 162) with videos related to

Pageof 17
Sort By:
Virchows Archiv : an International Journal of Pathology|June 27, 2008
Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriersAnnegret Müller, Dirk Zielinski, Nicolaus Friedrichs, et al.
Cancers|April 3, 2021
Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based ApproachesJanna Siemanowski, Birgid Schömig-Markiefka, Theresa Buhl, et al.
Human Pathology|February 5, 2017
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare eventsSebastian Huss, Helen Pasternack, Michaela Angelika Ihle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)Sebastian Huss, Helen Künstlinger, Eva Wardelmann, et al.
The Journal of Molecular Diagnostics : JMD|July 22, 2017
Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation TestingChristina Alidousty, Danielle Brandes, Carina Heydt, et al.
Molecular Oncology|April 23, 2015
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumoursMichaela Angelika Ihle, Marcel Trautmann, Helen Kuenstlinger, et al.
International Journal of Surgical Pathology|November 8, 2005
Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entityNicolaus Friedrichs, Maria Adele Testi, Luisa Moiraghi, et al.
The American Journal of Surgical Pathology|August 30, 2008
Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822YAndreas Thalheimer, Marcus Schlemmer, Marco Bueter, et al.
Gastroenterology|September 7, 2005
Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosisKarin Hartmann, Eva Wardelmann, Yongsheng Ma, et al.
Cancers|May 14, 2025
Assessment of p53 in Endometrial Carcinoma Biopsy and Corresponding Hysterectomy Cases in a Real-World Setting: Which Cases Need Molecular Work-Up?Marie-Lisa Eich, Janna Siemanowsk-Hrach, Uta Drebber, et al.
Pageof 17

Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
Virchows Archiv : an International Journal of Pathology|June 27, 2008
Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriersAnnegret Müller, Dirk Zielinski, Nicolaus Friedrichs, et al.
Cancers|April 3, 2021
Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based ApproachesJanna Siemanowski, Birgid Schömig-Markiefka, Theresa Buhl, et al.
Human Pathology|February 5, 2017
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare eventsSebastian Huss, Helen Pasternack, Michaela Angelika Ihle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)Sebastian Huss, Helen Künstlinger, Eva Wardelmann, et al.
The Journal of Molecular Diagnostics : JMD|July 22, 2017
Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation TestingChristina Alidousty, Danielle Brandes, Carina Heydt, et al.
Molecular Oncology|April 23, 2015
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumoursMichaela Angelika Ihle, Marcel Trautmann, Helen Kuenstlinger, et al.
International Journal of Surgical Pathology|November 8, 2005
Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entityNicolaus Friedrichs, Maria Adele Testi, Luisa Moiraghi, et al.
The American Journal of Surgical Pathology|August 30, 2008
Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822YAndreas Thalheimer, Marcus Schlemmer, Marco Bueter, et al.
Gastroenterology|September 7, 2005
Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosisKarin Hartmann, Eva Wardelmann, Yongsheng Ma, et al.
Cancers|May 14, 2025
Assessment of p53 in Endometrial Carcinoma Biopsy and Corresponding Hysterectomy Cases in a Real-World Setting: Which Cases Need Molecular Work-Up?Marie-Lisa Eich, Janna Siemanowsk-Hrach, Uta Drebber, et al.
Pageof 17